LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged terminal disclaimers · clear

Federal Circuit

A Terminal Disclaimer Is Not an Escape Hatch

Written by : Nefi R. Oliva & Nathan D. Reeves IN RE CELLECT, LLC Before Lourie , Dyk, and Reyna. Appeal from the Patent Trial and Appeal Board. Summary : Obviousness-type double patenting analyses for patents with Patent Term Adjustments are based on the…

August 30, 2023·Federal Circuit·2 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.